These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical and pathologic features of families with LRRK2-associated Parkinson's disease. Whaley NR; Uitti RJ; Dickson DW; Farrer MJ; Wszolek ZK J Neural Transm Suppl; 2006; (70):221-9. PubMed ID: 17017533 [TBL] [Abstract][Full Text] [Related]
3. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia. Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990 [TBL] [Abstract][Full Text] [Related]
4. LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8. Nichols WC; Elsaesser VE; Pankratz N; Pauciulo MW; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T; Neurology; 2007 Oct; 69(18):1737-44. PubMed ID: 17804834 [TBL] [Abstract][Full Text] [Related]
5. LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation. Lorenzo-Betancor O; Samaranch L; Ezquerra M; Tolosa E; Lorenzo E; Irigoyen J; Gaig C; Pastor MA; Soto-Ortolaza AI; Ross OA; Rodríguez-Oroz MC; Valldeoriola F; Martí MJ; Luquin MR; Perez-Tur J; Burguera JA; Obeso JA; Pastor P Mov Disord; 2012 Jan; 27(1):146-51. PubMed ID: 22038903 [TBL] [Abstract][Full Text] [Related]
6. Clinical and positron emission tomography of Parkinson's disease caused by LRRK2. Hernandez DG; Paisán-Ruíz C; McInerney-Leo A; Jain S; Meyer-Lindenberg A; Evans EW; Berman KF; Johnson J; Auburger G; Schäffer AA; Lopez GJ; Nussbaum RL; Singleton AB Ann Neurol; 2005 Mar; 57(3):453-6. PubMed ID: 15732108 [TBL] [Abstract][Full Text] [Related]
7. LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901 [TBL] [Abstract][Full Text] [Related]
9. LRRK2 mutations are a common cause of Parkinson's disease in Spain. Mata IF; Ross OA; Kachergus J; Huerta C; Ribacoba R; Moris G; Blazquez M; Guisasola LM; Salvador C; Martinez C; Farrer M; Alvarez V Eur J Neurol; 2006 Apr; 13(4):391-4. PubMed ID: 16643318 [TBL] [Abstract][Full Text] [Related]
10. Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes. Hasegawa K; Stoessl AJ; Yokoyama T; Kowa H; Wszolek ZK; Yagishita S Parkinsonism Relat Disord; 2009 May; 15(4):300-6. PubMed ID: 18804399 [TBL] [Abstract][Full Text] [Related]
11. An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Funayama M; Hasegawa K; Ohta E; Kawashima N; Komiyama M; Kowa H; Tsuji S; Obata F Ann Neurol; 2005 Jun; 57(6):918-21. PubMed ID: 15880653 [TBL] [Abstract][Full Text] [Related]
12. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964 [TBL] [Abstract][Full Text] [Related]
13. LRRK2 R1441G in Spanish patients with Parkinson's disease. Mata IF; Taylor JP; Kachergus J; Hulihan M; Huerta C; Lahoz C; Blazquez M; Guisasola LM; Salvador C; Ribacoba R; Martinez C; Farrer M; Alvarez V Neurosci Lett; 2005 Jul; 382(3):309-11. PubMed ID: 15925109 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Kachergus J; Mata IF; Hulihan M; Taylor JP; Lincoln S; Aasly J; Gibson JM; Ross OA; Lynch T; Wiley J; Payami H; Nutt J; Maraganore DM; Czyzewski K; Styczynska M; Wszolek ZK; Farrer MJ; Toft M Am J Hum Genet; 2005 Apr; 76(4):672-80. PubMed ID: 15726496 [TBL] [Abstract][Full Text] [Related]
15. A study of LRRK2 mutations and Parkinson's disease in Brazil. Pimentel MM; Moura KC; Abdalla CB; Pereira JS; de Rosso AL; Nicaretta DH; Campos M; de Almeida RM; dos Santos JM; Bastos IC; Mendes MF; Maultasch H; Costa FH; Werneck AL; Santos-Rebouças CB Neurosci Lett; 2008 Mar; 433(1):17-21. PubMed ID: 18201824 [TBL] [Abstract][Full Text] [Related]
16. Clinical features of LRRK2-associated Parkinson's disease in central Norway. Aasly JO; Toft M; Fernandez-Mata I; Kachergus J; Hulihan M; White LR; Farrer M Ann Neurol; 2005 May; 57(5):762-5. PubMed ID: 15852371 [TBL] [Abstract][Full Text] [Related]
17. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Zabetian CP; Samii A; Mosley AD; Roberts JW; Leis BC; Yearout D; Raskind WH; Griffith A Neurology; 2005 Sep; 65(5):741-4. PubMed ID: 16157909 [TBL] [Abstract][Full Text] [Related]
18. LRRK2 in Parkinson's disease: protein domains and functional insights. Mata IF; Wedemeyer WJ; Farrer MJ; Taylor JP; Gallo KA Trends Neurosci; 2006 May; 29(5):286-93. PubMed ID: 16616379 [TBL] [Abstract][Full Text] [Related]
19. Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients. Floris G; Cannas A; Solla P; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Sardu C; Marrosu F; Marrosu MG Parkinsonism Relat Disord; 2009 May; 15(4):277-80. PubMed ID: 18805725 [TBL] [Abstract][Full Text] [Related]
20. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]